Trastuzumab Terminated Phase 2 Trials for Her2-Positive Breast Cancer / Recurrent Breast Cancer / Stage IV Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00079326Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer